Graviton Bioscience
0 followers
‌
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.
Industries
+1
Headquarters
Employees
Links
Org chart
Samuel Waksal
Chief Executive Officer
Samuel Waksal
Collapse
Amy Melsaether
Chief Medical Officer
Robert Jan Lamers
Managing Director
Rui Wu
Svp, Head Of Research & Preclinical. Chief CMC Officer
Andrew Wojcik
VP Clinical Quality And Compliance
Heeyoung P.
Vice President, Regulatory
Emmanuelle Zaoui
Vice President Of AI & Operations
Julia Balanova
Vp, Corporate Strategy And Communications
Justin Stebbing
Senior VP Clinical Strategy And Innovation
